Keywords: neupogen, approved, bmt, usa, amgen, filgrastim, been

NEUPOGEN APPROVED FOR BMT IN USA

Article | 27 June 1994

Print This

Amgen's Neupogen (filgrastim) has been cleared by the US Food and Drug Administration for use in bone marrow transplantation patients. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in